Mathias Oelke
Chief Science Officer, NexImmune, Inc.
Companies
- NexImmune, Inc.Chief Science Officer Apr 7, 2022 to Apr 6, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NexImmune, Inc.134,023 shares2Nov 22, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 22, 2022Granted 126,100 shares of NexImmune, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2